Urogen Pharma (URGN) Surges 9.7%: Is This an Indication of Further Gains?

Urogen Pharma (URGN) shares soared 9.7% in the last trading session to close at $19.20. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 32.5% gain over the past four weeks. This company is expected to post quarterly loss of $0.88 per share in its upcoming report, which represents a year-over-year change of +14.6%. Revenues are expected to be $23.69 million, up 12% from the year-ago quarter. For Urogen Pharma, the consensus EPS es ...